Liminatus Pharma Inc. to Launch 'American BNB Strategy' Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
The company intends to establish a dedicated subsidiary, named 'American BNB Strategy,' to lead its digital asset investment and management initiatives. Through this planned vehicle, Liminatus aims to raise and deploy up to $500 million in phases, targeting strategic, long-term investments in BNB coin (Build and Build) the native token of the Binance ecosystem, the world's largest digital asset exchange.
This announcement follows an internal review of blockchain-integrated financial strategies conducted over the past several weeks.
Liminatus emphasized that while it remains fully committed to its core business — advancing cancer therapeutics and developing pancreatic cancer diagnostics — the company believes that expanding into the digital asset space is a necessary step to support long-term growth and enhance shareholder value.
The proposed subsidiary, 'American BNB Strategy,' is expected to focus on the strategic and structured acquisition and long-term holding of BNB Coin, utilizing capital raised through the planned fund. The company clarified that this is not a short-term speculative initiative, but rather a value driven strategy based on the long-term growth potential and strength of the BNB ecosystem.
Chris Kim, CEO of Liminatus, stated that BNB Coin was selected over numerous digital assets due to its robust technology, global user base, value generating features such as Launchpool participation and staking models, and the ongoing expansion of the BNB Chain.
He added that Liminatus expects to utilize custody infrastructure provided by Ceffu, an affiliated entity within the BNB ecosystem, to ensure institutional grade security and operational integrity. The company believes this approach will enable a secure and compliant entry into the digital asset sector and support its long-term capital strategy.
Establishing a dedicated subsidiary for large-scale cryptocurrency investment and designating a specific blockchain token as a core treasury asset is a rare move for a traditional biopharmaceutical company. Liminatus believes this bold initiative could set a precedent for how other Nasdaq listed companies approach participation in the digital asset economy.
As of the date of this announcement, Liminatus is actively engaged in a capital raise process in collaboration with placement agent Digital Offering, and the Board is in the process of finalizing its review and approval. The initiative remains subject to regulatory clearance and prevailing market conditions.
About Liminatus Pharma, Inc.
Liminatus is a preclinical-stage biopharmaceutical company developing immunotherapies for patients with cancer. The Company is advancing a pipeline of novel therapies targeting cancer antigens and tumor-specific immune responses. Liminatus is also committed to responsible innovation in capital strategy to support its long-term scientific and operational objectives.
Forward-Looking Statements
Certain statements in this press release constitute forward-looking statements. Forward-looking statements include, but are not limited to, statements regarding management's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intends,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'will,' 'would' and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects. Future developments affecting Liminatus may not be those that Liminatus has anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of Liminatus), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. Liminatus undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.
In addition, statements that 'we believe' and similar statements reflect beliefs and opinions on the relevant subject. These statements are based upon information available to Liminatus as of the date of this press release, and while Liminatus believes such information forms a reasonable basis for such statements, such information may be limited or incomplete, and such statements should not be read to indicate that Liminatus has conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements as predictions of future results. Liminatus's actual future results may be materially different from what it expects. Liminatus qualifies all forward-looking statements by these cautionary statements.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
2 minutes ago
- CTV News
Tariffs trigger layoffs and closures in Quebec as U.S. trade war deepens
Layoffs have begun and at least one Quebec business has shut down, as the effects of new U.S. tariffs ripple through the province, a clear sign the trade war with the United States is escalating. U.S. President Donald Trump signed an executive order increasing tariffs on Canadian goods from 25 per cent to 35 per cent on products not covered by the United States-Mexico-Canada Agreement (USMCA). For many Montrealers, the latest news is a reminder to buy local. On Facebook, a lumber mill in Saint-Michel-des-Saints, two hours north of Montreal, announced it was letting go of 250 employees and suspending its activities until October, and cited tariffs as the reason. Another company based in Saint-Georges, known for manufacturing semi-trailers, is planning to lay off more than a hundred workers. Economist Julian Karaguesian said more companies could potentially face the same fate. 'At the local, regional level, we can see more closures, more unemployed,' he said. Karaguesian added that in Quebec, the aluminum and steel industries are being hit the hardest, as tariffs are already high in those sectors. 'The 50 per cent tariffs on steel. And now there's 50 per cent tariffs on certain copper products. Those are hurting more than the previous 25 per cent tariff, which is now 35 per cent.' On X, Premier François Legault wrote that the tariffs are harmful to businesses and workers, and that it was important for Quebec to diversify its markets. 'President Trump is shaking up the system, and we have an opportunity in this crisis to build out our export markets and to build a Canadian economy once more,' Karaguesian said.
Globe and Mail
an hour ago
- Globe and Mail
Better Artificial Intelligence Stock: BigBear.ai vs. Nvidia
Key Points has become an AI investor darling over the past few years. Nvidia is the leading artificial intelligence semiconductor company. There's no substitute for high revenue growth and profitability -- and Nvidia has both. 10 stocks we like better than Nvidia › Many investors are focused on artificial intelligence stocks these days, which can be a smart play as AI transforms many industries. But it's starting to seem like any AI stock is a winner in the market right now, which means some investors may not be doing their due diligence when evaluating companies. With that in mind, two AI companies with surging share prices right now are Nvidia (NASDAQ: NVDA) and (NYSE: BBAI), and it may be worth taking a closer look at both to see which one looks like the better AI stock to buy right now. What's happening with Nvidia Nvidia gets top billing in this matchup because the company has experienced monster growth over the past few years as companies clamor for its artificial intelligence semiconductors. An estimated 70% to 95% of data centers utilize Nvidia's AI processors, and there seems to be no slowing down for the company's growth. For example, Nvidia's total sales soared 114% in fiscal 2025 to $130.5 billion, and its earnings skyrocketed 147% to $2.94 per share. This growth has been fueled by the company's data center segment, which experienced a 142% revenue surge to $115 billion last year. The impressive earnings and revenue growth have resulted in Nvidia's stock surging 57% over the past year. That's pushed the company's valuation higher, and Nvidia's shares currently have a price-to-earnings multiple of about 56. That's not cheap, but it's still lower than the average P/E ratio of 64 in the semiconductor industry right now. What's more, Nvidia could continue to benefit from AI investments for many more years to come. Nvidia CEO Jensen Huang believes AI will fuel $2 trillion in data center spending over the next several years. While Nvidia's growth isn't guaranteed, many tech giants have already committed to spending hundreds of billions of dollars to expand their AI data centers over the next few years. That's creating an ongoing opportunity for Nvidia to continue increasing its sales. What's happening with is an AI data analytics company that helps companies and the U.S. government sort through their data to make decisions. AI analytics is a burgeoning AI trend, and it has propelled the stock of similar companies, like Palantir, into the stratosphere. stock, for its part, has jumped 323% over the past year. But despite its impressive gains, there are some significant concerns I have with including its lack of strong revenue growth. sales increased just 5% in Q1 to $34.8 million, and management's outlook for the full year is for $160 million to $180 million -- an increase of just 7.5% at the midpoint. These are fairly unimpressive sales figures for a small AI company that's trying to tap into an expanding artificial intelligence analytics market. One of the company's problems is that 52% of its revenue comes from just four customers. That's a high concentration of sales from just a handful of customers, and it means that if one or two leave, could be in trouble. And then there's the company's lack of earnings. reported a loss of $1.10 per share last year and continued that trend with a loss of $0.25 per share in Q1. While many small start-ups often aren't profitable, it's problematic that the company's lack of earnings comes in addition to unimpressive sales growth. Meanwhile, stock has a price-to-sales ratio of 11, which is substantially higher than the average P/S multiple of 3 for the S&P 500 and means that investors are paying a premium for it right now. Verdict: Nvidia is the hands-down winner Nvidia's stock isn't cheap, and there are always risks with investing in AI stocks that have already experienced astronomical growth. But the company is a hands-down better investment than because it's massively profitable, continually expanding its revenue, and outpaces its rivals in the AI semiconductor market. Meanwhile, stock is overvalued, its revenue growth is unimpressive, and the company isn't profitable. This makes Nvidia the no-brainer in this matchup and one of the best AI stocks to buy and hold for the long term. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $624,823!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,064,820!* Now, it's worth noting Stock Advisor's total average return is 1,019% — a market-crushing outperformance compared to 178% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 29, 2025
Globe and Mail
2 hours ago
- Globe and Mail
Amazon's Earnings: What Comes Next and How to Play It
Shares of tech giant Inc. (NASDAQ: AMZN) finished Thursday's session up nearly 2%, only to tumble more than 6% in after-hours trading following the company's Q2 earnings release. This sharp reversal underlines just how high expectations had gotten after the 40% rally from April's low. The stock's multi-month move meant anything less than a near-perfect report risked triggering a wave of profit-taking, and that appears to be exactly what's happening already. As we'll see below, however, this is also creating a couple of interesting plays for investors to consider depending on their belief in Amazon's potential over the long run, and their near-term appetite for risk. Let's jump in and take a look. The Report Looked Good, But It Had to Be Great At first glance, Amazon seemed to deliver. The company's earnings per share came in more than 25% above expectations, while revenue was up 13.3% year-over-year. Both metrics landed hot and were well above analyst expectations, adding to Amazon's impressive track record of delivering strong headline numbers quarter on quarter. But investors weren't satisfied based on the after-hours price action. As anticipated earlier in the week, any sign of weakness in last night's report could send the bulls running and the bears raging. And Amazon's weaker-than-expected guidance for operating income and some free cash flow concerns seem to have done just that. The range shared by management on the former was notably conservative, while the latter figure is now at its lowest in two years. In that context, it's perhaps not all that hard to see what investor sentiment would swing from risk-on to risk-off so quickly. It remains to be seen how long this switch will last, but in our view, there's little to be worried about regarding Amazon's long-term potential. What the Market Might Be Missing While the overnight sell-off might feel sharp, it's also arguably overdone. This was still an impressive report for Amazon, with revenue growth accelerating across the board and profitability improving at the same time. Overall growth remains strong despite ongoing infrastructure investments and competitive pricing pressures. The bears will point to growing concerns around the company's ability to stay in the lead group of the artificial intelligence (AI) arms race, but CEO Andy Jassy was not overly concerned. He spoke about this on the post-earnings conference call, saying, "I don't believe that we will have fully resolved the capacity we need for the amount of demand that we have in a couple of quarters. I think it will take several quarters, but I do expect that it's going to get better each quarter". Taken in total, there's a strong case to be made that Amazon is still in the early innings of its next growth phase, and Thursday's after-hours drop is more about positioning than fundamentals. 2 Ways to Play It For those of us on the sidelines, what kind of plays should we be looking for? Option one might be to sit back and let the correction play out. A move down to around the $220 level would take the stock back to a key area of support, and, given how one-directional the recent rally has been, would actually be quite healthy. If that $220 level were to hold, and or if we were to see a fresh bullish crossover in the MACD, it would likely mark the start of the next leg higher. Waiting for confirmation here gives you better risk/reward and protects against a deeper pullback. The other option is to start accumulating right away. This argument rests on the idea that Amazon's core thesis remains intact and the bears' concerns are already, or at least close to being, priced in after last night's drop. For big-time believers and long-term investors, this dip could be a gift - especially considering the company's strength across multiple verticals and its growing strength in high-margin, AI-driven businesses. Remember, multiple firms have been reiterating their Buy and Overweight ratings all through 2025, and even as recently as this week. The most recent price target from the team over at UBS Group sees the stock trading north of $270, a move that points to additional upside of around 15% from current levels. Don't expect their bullishness, and that of their peers, to change anytime soon. Before you make your next trade, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list. They believe these five stocks are the five best companies for investors to buy now...
